Results 291 to 300 of about 1,472,301 (348)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2005
In the United States, renal cancer is the 7th leading malignant condition in men and the 12th in women, accounting for 2.6 percent of all cancers. This article discusses the evolving presentation, understanding, and treatment of this disease.
Herbert T, Cohen, Francis J, McGovern
openaire +5 more sources
In the United States, renal cancer is the 7th leading malignant condition in men and the 12th in women, accounting for 2.6 percent of all cancers. This article discusses the evolving presentation, understanding, and treatment of this disease.
Herbert T, Cohen, Francis J, McGovern
openaire +5 more sources
The Lancet, 2009
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. In localised disease, partial nephrectomy for small tumours and radical nephrectomy for large tumours continue to be the gold-standard treatments, with emphasis on ...
Brian I, Rini +2 more
openaire +4 more sources
Considerable progress has been made in the treatment of patients with renal cell carcinoma, with innovative surgical and systemic strategies revolutionising the management of this disease. In localised disease, partial nephrectomy for small tumours and radical nephrectomy for large tumours continue to be the gold-standard treatments, with emphasis on ...
Brian I, Rini +2 more
openaire +4 more sources
Epidemiology of Renal Cell Carcinoma: 2022 Update.
European Urology, 2022CONTEXT International variations in the rates of kidney cancer (KC) are considerable. An understanding of the risk factors for KC development is necessary to generate opportunities to reduce its incidence through prevention and surveillance.
L. Bukavina +15 more
semanticscholar +1 more source
Current Opinion in Oncology, 2000
The overall incidence of renal cell carcinoma is rising, for reasons not fully explained by increased abdominal imaging. Risk factors associated with renal cell carcinoma include hypertension, smoking, increased body mass index, and diet. There is an inverse association of renal cell carcinoma risk with consumption of a variety of carotenes.
P A, Godley, K I, Ataga
openaire +2 more sources
The overall incidence of renal cell carcinoma is rising, for reasons not fully explained by increased abdominal imaging. Risk factors associated with renal cell carcinoma include hypertension, smoking, increased body mass index, and diet. There is an inverse association of renal cell carcinoma risk with consumption of a variety of carotenes.
P A, Godley, K I, Ataga
openaire +2 more sources
Medical Clinics of North America, 1975
The natural history, presenting signs and symptoms, and radiologic evaluation of patients with hypernephroma are reviewed. Radical nephrectomy is the treatment of choice in patients free of metastatic disease. Patients who have evidence of metastatic disease should not be subjected to nephrectomy unless hemorrhage, pain, or some other severe local ...
J A, Libertino, L, Zinman
openaire +2 more sources
The natural history, presenting signs and symptoms, and radiologic evaluation of patients with hypernephroma are reviewed. Radical nephrectomy is the treatment of choice in patients free of metastatic disease. Patients who have evidence of metastatic disease should not be subjected to nephrectomy unless hemorrhage, pain, or some other severe local ...
J A, Libertino, L, Zinman
openaire +2 more sources
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Cell, 2017 Summary Immune cells in the tumor microenvironment modulate cancer progression and are attractive therapeutic targets. Macrophages and T cells are key components of the microenvironment, yet their phenotypes and relationships in this ecosystem and to ...
Stephane Chevrier +2 more
exaly +2 more sources
Current Opinion in Oncology, 1998
Renal cell carcinoma (RCC) continues to be a frustrating tumor for clinicians to manage and treat. Progress has been made in the identification of risk factors, particularly dietary risk factors. An increased risk has been seen with frequent consumption of fried meat and poultry.
P A, Godley, M A, Escobar
openaire +2 more sources
Renal cell carcinoma (RCC) continues to be a frustrating tumor for clinicians to manage and treat. Progress has been made in the identification of risk factors, particularly dietary risk factors. An increased risk has been seen with frequent consumption of fried meat and poultry.
P A, Godley, M A, Escobar
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2011 Renal Cell Carcinoma (RCC) has the highest mortality rate of the genitourinary cancers and the incidence of RCC has risen steadily. If detected early, RCC is curable by surgery although a minority are at risk of recurrence. Increasing incidental detection and an ageing population has led to active surveillance as an option for patients with small renal
openaire +4 more sources
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
Nature Reviews Clinical Oncology, 2021 David A Braun +2 more
exaly +2 more sources
Current Opinion in Oncology, 2002
Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to spread asymptomatically and its inherent resistance to conventional chemotherapy. However, molecular genetic studies bring new insights into the pathogenesis of this disorder and may provide new targets against which novel chemotherapeutic agents could be ...
Paul, Godley, Steven W, Kim
openaire +2 more sources
Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to spread asymptomatically and its inherent resistance to conventional chemotherapy. However, molecular genetic studies bring new insights into the pathogenesis of this disorder and may provide new targets against which novel chemotherapeutic agents could be ...
Paul, Godley, Steven W, Kim
openaire +2 more sources